Start-Ups Swimming ...
Health Care: Drugs
Theravance Inc. (THRX: NASDAQ)
$36.24 -0.54 | -1.47%
05/24/13 - 04:00 PM ET
1.07M / 1.54M
Vol / Avg. Vol:36.62 / 36.78
Open / Prev. Close:36.04 - 36.62
Today's Range:17.06 - 42.41
52 Wk Range:65.38%
Performance YTD:TheStreet Rating:
Portfolios with THRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ProSeth Klarman - Baupost Group
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Usernew
Latest THRX Headlines from TheStreet
- Stocks Finish Flat as Earnings Wind Down 05.13.13 | 11:05 am
- Stock Futures Lower Ahead of Retail Sales 05.13.13 | 06:05 am
- 4 Stocks Spiking on Big Volume 05.10.13 | 03:05 pm
- Buffett's Long-Term, High-Dividend Plays 05.04.13 | 03:05 am
- Theravance Inc. (THRX): Today's Featured Health Care Laggard 04.19.13 | 05:04 pm
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 5 Stocks Poised to Pop on Bullish Earnings 02.11.13 | 12:02 pm
- Insiders Trading THRX KSS TUES ELGX 11.06.12 | 10:11 am
- Theravance And Merck Sign Cardiovascular Disease Collaboration 10.16.12 | 08:10 am
- Theravance And Alfa Wassermann Enter Into Agreement To Develop And Commercialize Velusetrag For Gastroparesis 10.02.12 | 04:10 pm
Press Releases for THRX
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
Partner Headlines for THRX
- Morning Market Movers - Benzinga 04.15.13 | 09:04 am
- Pipeline Progress at Theravance - Analyst Blog - Zacks 12.05.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Loss at THRX Narrower Than Expected - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Pipeline Advances at Glaxo/THRX - Analyst Blog - NASDAQ 08.27.12 | 08:08 pm
- Weekly CFO Sells Highlight: SWN, BECN, NSIT, HOLX, QLTI, THRX - GuruFocus 08.13.12 | 08:08 pm
